Effects and systemic uptake of the new mitomycin C analogue KW-2149 in beagle dogs after intravesical administration
✍ Scribed by Sorber, M. ;De Bruijn, E. A. ;Kockx, M. ;Bultinck, J. ;Van Oosterom, A. T. ;Denis, L.
- Publisher
- Springer
- Year
- 1995
- Tongue
- English
- Weight
- 609 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0300-5623
No coin nor oath required. For personal study only.
✦ Synopsis
The present study was designed to evaluate the local effects of the new mitomycin C analogue KW-2149 after intravesical instillation, together with its penetration into the systemic circulation in healthy beagle dogs. Two reference dogs were treated with two instillations of mitomycin C (30 mg in 30 ml phosphate buffer). Four dogs were given two, three, four and six instillations, respectively, of KW-2149 (60 mg in 30 ml phosphate buffer). KW-2149 concentrations measured in the systemic circulation were very low and were frequently found to be below the limit of determination. The number of instillations had no influence on the KW-2149 concentrations measured in the systemic circulation. Blood analysis showed no systemic toxicity. The histopathological findings in the bladder were comparable in both groups. The number of instillations had no influence on the severity of the lesions found in the bladder wall. On the basis of its in vitro activity KW-2149 can be regarded as a promising agent for intravesical treatment of superficial bladder cancer. Key words Mitomycins. Bladder' Systemic uptake. Toxicity-Urothelium 9 Dogs Superficial transitional cell carcinoma of the bladder is easily accessible with intravesical treatment. Tumor recurrence is common and can be accompanied by stage and/or grade progression. The efficacy of